rs397515445
Variant summary
Our verdict is Pathogenic. Variant got 12 ACMG points: 12P and 0B. PM1PM2PM5PP2PP3_StrongPP5
The NM_023110.3(FGFR1):c.2075A>G(p.Glu692Gly) variant causes a missense change involving the alteration of a conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a pathogenic outcome for this variant. 13/21 in silico tools predict a damaging outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. E692K) has been classified as Pathogenic.
Frequency
Consequence
NM_023110.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 12 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
FGFR1 | NM_023110.3 | c.2075A>G | p.Glu692Gly | missense_variant | 16/18 | ENST00000447712.7 | NP_075598.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
FGFR1 | ENST00000447712.7 | c.2075A>G | p.Glu692Gly | missense_variant | 16/18 | 1 | NM_023110.3 | ENSP00000400162.2 | ||
FGFR1 | ENST00000397091.9 | c.2069A>G | p.Glu690Gly | missense_variant | 16/18 | 1 | ENSP00000380280.5 | |||
FGFR1 | ENST00000397108.8 | c.2069A>G | p.Glu690Gly | missense_variant | 17/19 | 1 | ENSP00000380297.4 | |||
FGFR1 | ENST00000397113.6 | c.2069A>G | p.Glu690Gly | missense_variant | 16/18 | 2 | ENSP00000380302.2 | |||
FGFR1 | ENST00000356207.9 | c.1808A>G | p.Glu603Gly | missense_variant | 15/17 | 1 | ENSP00000348537.5 | |||
FGFR1 | ENST00000397103.5 | c.1808A>G | p.Glu603Gly | missense_variant | 14/16 | 5 | ENSP00000380292.1 | |||
FGFR1 | ENST00000326324.10 | c.1802A>G | p.Glu601Gly | missense_variant | 15/17 | 1 | ENSP00000327229.6 |
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD4 exome Cov.: 32
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
Hypogonadotropic hypogonadism 2 with or without anosmia Pathogenic:1
Likely pathogenic, criteria provided, single submitter | research | Reproductive Endocrine Unit, Massachusetts General Hospital | May 04, 2023 | The variant has been classified as LP6 based on the variant meeting the following ACMG Criteria: PM2,PP3,PP1,PP2,PP4. - |
Pfeiffer syndrome;C1563720:Hypogonadotropic hypogonadism 2 with or without anosmia Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Aug 25, 2023 | In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. This variant disrupts the p.Glu692 amino acid residue in FGFR1. Other variant(s) that disrupt this residue have been observed in individuals with FGFR1-related conditions (PMID: 31996231), which suggests that this may be a clinically significant amino acid residue. Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is expected to disrupt FGFR1 protein function. ClinVar contains an entry for this variant (Variation ID: 50851). This missense change has been observed in individual(s) with FGFR1-related conditions (PMID: 23643382). This variant is not present in population databases (gnomAD no frequency). This sequence change replaces glutamic acid, which is acidic and polar, with glycine, which is neutral and non-polar, at codon 692 of the FGFR1 protein (p.Glu692Gly). - |
Hypogonadotropic hypogonadism 2 with anosmia Other:1
risk factor, no assertion criteria provided | literature only | OMIM | May 02, 2013 | - - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at